{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:46:13Z","timestamp":1757310373977},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T00:00:00Z","timestamp":1547596800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cryptococcus neoformans and Cryptococcus gattii species complexes have a worldwide distribution; however, there is geographical variation in the prevalence of different molecular types. Additionally, antifungal susceptibility differences between molecular types have been demonstrated. This study investigates the distribution of cryptococcal molecular types among human clinical isolates over a 10-year period from a Western Australian population. Molecular type was determined based on polymorphisms in the phospholipase gene locus identified through amplification and sequencing. Minimum inhibitory concentrations (MICs) were identified for fluconazole, 5-fluorocytosine, posaconazole, itraconazole, voriconazole, and amphotericin B. Most isolates were C. neoformans complex (42) of which over half were molecular type VNI (22) followed by VNII (20). Among the remaining C. gattii complex (13) the majority were VGI (11) with VGII (2) uncommonly found. All isolates demonstrated low MICs to antifungal agents including fluconazole. Geometric mean MIC values against 5-fluorocytosine for VNI (1.741\u00a0mg\/l) were significantly higher than those for VGI (0.47\u00a0mg\/l, P = .002). Similarly fluconazole geometric mean MICs against fluconazole for VNI (2.3\u00a0mg\/l) were significantly higher than VNII (0.87\u00a0mg\/l, P = .036). These data reveal the presence of four molecular types (VNI, VNII, VGI and VGII) within clinical Western Australian cryptococcal isolates and, while elevated antifungal MICs were not encountered, significant molecular type dependent differences in susceptibility were found.<\/jats:p>","DOI":"10.1093\/mmy\/myy161","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T12:29:34Z","timestamp":1545308974000},"page":"1004-1010","source":"Crossref","is-referenced-by-count":20,"title":["Molecular types of Cryptococcus neoformans and Cryptococcus gattii in Western Australia and correlation with antifungal susceptibility"],"prefix":"10.1093","volume":"57","author":[{"given":"Gar-hing Andrew","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Microbiology, PathWest Laboratory Medicine WA, QEII Medical Centre, Hospital Avenue, Nedlands, Western Australia, 6009"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Arthur","sequence":"additional","affiliation":[{"name":"Department of Microbiology, PathWest Laboratory Medicine WA, QEII Medical Centre, Hospital Avenue, Nedlands, Western Australia, 6009"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Merritt","sequence":"additional","affiliation":[{"name":"Department of Microbiology, PathWest Laboratory Medicine WA, QEII Medical Centre, Hospital Avenue, Nedlands, Western Australia, 6009"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Microbiology, PathWest Laboratory Medicine WA, QEII Medical Centre, Hospital Avenue, Nedlands, Western Australia, 6009"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"key":"2019100313120000200_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 Update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2019100313120000200_bib2","doi-asserted-by":"crossref","first-page":"e00357","DOI":"10.1128\/mSphere.00357-16","article-title":"The case for adopting the \u201cspecies complex\u201d nomenclature for the etiologic agents of cryptococcosis","volume":"2","author":"Kwon-Chung","year":"2017","journal-title":"mSphere"},{"key":"2019100313120000200_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0002297","article-title":"Molecular epidemiology reveals genetic diversity amongst isolates of the Cryptococcus neoformans\/C. gattii species complex in Thailand","volume":"7","author":"Kaocharoen","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2019100313120000200_bib4","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/myc.12539","article-title":"Molecular epidemiology reveals genetic diversity among 363 isolates of the Cryptococcus neoformans and Cryptococcus gattii species complex in 61 Ivorian HIV-positive patients","volume":"59","author":"Kassi","year":"2016","journal-title":"Mycoses"},{"key":"2019100313120000200_bib5","doi-asserted-by":"crossref","first-page":"e94648","DOI":"10.1371\/journal.pone.0094648","article-title":"Identification of the major molecular types of Cryptococcus neoformans and C. gattii by hyperbranched rolling circle amplification","volume":"9","author":"Trilles","year":"2014","journal-title":"PLoS One"},{"key":"2019100313120000200_bib6","doi-asserted-by":"crossref","first-page":"e00238","DOI":"10.1128\/mSphere.00238-17","article-title":"Importance of resolving fungal nomenclature: the case of multiple pathogenic species in the Cryptococcus genus","volume":"2","author":"Hagen","year":"2017","journal-title":"mSphere"},{"key":"2019100313120000200_bib7","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1128\/AAC.00746-10","article-title":"In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates","volume":"54","author":"Hagen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2019100313120000200_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/JCM.01505-09","article-title":"Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States","volume":"48","author":"Iqbal","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2019100313120000200_bib9","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1128\/JCM.01271-10","article-title":"In vitro susceptibility of the yeast pathogen Cryptococcus to fluconazole and other azoles varies with molecular genotype","volume":"48","author":"Chong","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2019100313120000200_bib10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1099\/jmm.0.029025-0","article-title":"In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India","volume":"60","author":"Chowdhary","year":"2011","journal-title":"J Med Microbiol"},{"key":"2019100313120000200_bib11","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/JCM.06750-11","article-title":"Extensive genetic diversity within the Dutch clinical Cryptococcus neoformans population","volume":"50","author":"Hagen","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2019100313120000200_bib12","first-page":"963","article-title":"Epidemiological trends of cryptococcosis in Italy: molecular typing and susceptibility pattern of Cryptococcus neoformans isolates collected during a 20-year period","volume":"56","author":"Cogliati","year":"2018","journal-title":"Med Mycol"},{"key":"2019100313120000200_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.diagmicrobio.2016.08.004","article-title":"In vitro antifungal susceptibility profiles of Cryptococcus species isolated from HIV-associated cryptococcal meningitis patients in Zimbabwe","volume":"86","author":"Nyazika","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2019100313120000200_bib14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1099\/00221287-147-4-891","article-title":"Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans","volume":"147","author":"Boekhout","year":"2001","journal-title":"Microbiology"},{"key":"2019100313120000200_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3201\/eid0902.020246","article-title":"Molecular typing of IberoAmerican Cryptococcus neoformans isolates","volume":"9","author":"Meyer","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"2019100313120000200_bib16","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1128\/JCM.30.5.1094-1097.1992","article-title":"Use of a dispersed repetitive DNA element to distinguish clinical isolates of Cryptococcus neoformans","volume":"30","author":"Spitzer","year":"1992","journal-title":"J Clin Microbiol"},{"key":"2019100313120000200_bib17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1472-765X.1996.tb00197.x","article-title":"Characterization of Cryptococcus neoformans by random DNA amplification","volume":"23","author":"Ruma","year":"1996","journal-title":"Lett Appl Microbiol"},{"key":"2019100313120000200_bib18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/13693780902953886","article-title":"Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii","volume":"47","author":"Meyer","year":"2009","journal-title":"Med Mycol"},{"key":"2019100313120000200_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol Syst Biol"},{"key":"2019100313120000200_bib20","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nmeth.2109","article-title":"jModelTest 2: more models, new heuristics and parallel computing","volume":"9","author":"Darriba","year":"2012","journal-title":"Nat Methods"},{"key":"2019100313120000200_bib21","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/10635150390235520","article-title":"A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood","volume":"52","author":"Guindon","year":"2003","journal-title":"Syst Biol"},{"key":"2019100313120000200_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1214\/aos\/1176344136","article-title":"Estimating the dimension of a model","volume":"6","author":"Schwarz","year":"1978","journal-title":"Ann Stat"},{"key":"2019100313120000200_bib23","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/molbev\/msw054","article-title":"MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets","volume":"33","author":"Kumar","year":"2016","journal-title":"Mol Biol Evol"},{"key":"2019100313120000200_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/BF02101694","article-title":"Dating of the human-ape splitting by a molecular clock of mitochondrial DNA","volume":"22","author":"Hasegawa","year":"1985","journal-title":"J Mol Evol"},{"key":"2019100313120000200_bib25","first-page":"11","article-title":"Genotyping of the Cryptococcus neoformans\/C. gattii species complex","volume":"41","author":"Meyer","year":"2010","journal-title":"Aust Biochem"},{"key":"2019100313120000200_bib26","first-page":"23","article-title":"Global Molecular Epidemiology of Cryptococcus neoformans and Cryptococcus gattii: an atlas of the molecular types","volume":"2013","author":"Cogliati","year":"2013","journal-title":"Scientifica (Cairo)"},{"key":"2019100313120000200_bib27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1534\/genetics.117.203836","article-title":"Tracing genetic exchange and biogeography of Cryptococcus neoformans var. grubii at the global population level","volume":"207","author":"Vanhove","year":"2017","journal-title":"Genetics"},{"key":"2019100313120000200_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/313992","article-title":"Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand","volume":"31","author":"Chen","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2019100313120000200_bib29","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1111\/mec.13260","article-title":"Comparative analyses of clinical and environmental populations of Cryptococcus neoformans in Botswana","volume":"24","author":"Chen","year":"2015","journal-title":"Mol Ecol"},{"key":"2019100313120000200_bib30","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/mec.13891","article-title":"Genomic epidemiology of Cryptococcus yeasts identifies adaptation to environmental niches underpinning infection across an African HIV\/AIDS cohort","volume":"26","author":"Vanhove","year":"2017","journal-title":"Mol Ecol"},{"key":"2019100313120000200_bib31","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1128\/CMR.00126-13","article-title":"Cryptococcus gattii infections","volume":"27","author":"Chen","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"2019100313120000200_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/13693780802512519","article-title":"Cryptococcosis in domestic animals in Western Australia: a retrospective study from 1995\u20132006","volume":"47","author":"McGill","year":"2009","journal-title":"Med Mycol"},{"key":"2019100313120000200_bib33","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1128\/CMR.00126-13","article-title":"Cryptococcus gattii infections","volume":"27","author":"Chen","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"2019100313120000200_bib34","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1128\/JCM.02316-09","article-title":"Comparison of the Vitek 2 antifungal susceptibility system with the clinical and laboratory standards institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution reference methods and with the Sensititre YeastOne and Etest techniques for in vitro detection of antifungal resistance in yeast isolates","volume":"48","author":"Cuenca-Estrella","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2019100313120000200_bib35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1128\/JCM.37.3.591-595.1999","article-title":"Multicenter comparison of the sensititre YeastOne colorimetric antifungal panel with the National Committee for Clinical Laboratory standards M27: a reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms","volume":"37","author":"Espinel-Ingroff","year":"1999","journal-title":"J Clin Microbiol"},{"key":"2019100313120000200_bib36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/AAC.01216-08","article-title":"Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans","volume":"53","author":"Thompson","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2019100313120000200_bib37","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1128\/JCM.43.5.2163-2167.2005","article-title":"Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)","volume":"43","author":"Pfaller","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2019100313120000200_bib38","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard M27-A3","author":"CLSI","year":"2008","edition":"3rd edn"},{"key":"2019100313120000200_bib39","doi-asserted-by":"crossref","first-page":"e0003847","DOI":"10.1371\/journal.pntd.0003847","article-title":"Genotypic diversity is associated with clinical outcome and phenotype in cryptococcal meningitis across Southern Africa","volume":"9","author":"Beale","year":"2015","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/57\/8\/1004\/30098467\/myy161.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T16:08:57Z","timestamp":1605715737000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/57\/8\/1004\/5289635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,15]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,1,15]]},"published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myy161","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,1,15]]}}}